33453-98-4

Basic information

• Product Name: N-(2-NITROISOTUTYL)-MORPHOLINE
• Synonyms: N-(2-NITROISOTUTYL)-MORPHOLINE;4-(2-Methyl-2-nitropropyl)Morpholine
• CAS NO: 33453-98-4
• Molecular Formula: C₈H₁₆N₂O₃
• Molecular Weight: 188.22
• Mol File: 33453-98-4.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 281.5°C at 760 mmHg
• Flash Point: 124.1°C
• Appearance: /
• Density: 1.094g/cm³
• Vapor Pressure: 0.00355mmHg at 25°C
• Refractive Index: 1.472
• CAS DataBase Reference: N-(2-NITROISOTUTYL)-MORPHOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-NITROISOTUTYL)-MORPHOLINE(33453-98-4)
• EPA Substance Registry System: N-(2-NITROISOTUTYL)-MORPHOLINE(33453-98-4)

Safety Data

• Hazardous Substances Data: 33453-98-4(Hazardous Substances Data)

Usage

General Description

N-(2-nitroisotutyl)-morpholine is a chemical compound with the molecular formula C8H16N2O3. It is a nitro-functional morpholine derivative that is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. N-(2-nitroisotutyl)-morpholine has been shown to have antimicrobial properties, and it is also used as a corrosion inhibitor in metalworking fluids and as a stabilizer in industrial products. The compound is considered to be hazardous, and exposure to it can cause irritation to the skin, eyes, and respiratory system. It is important to handle N-(2-nitroisotutyl)-morpholine with care and to follow strict safety protocols when using it in laboratory or industrial settings.

InChI:InChI=1/C8H16N2O3/c1-8(2,10(11)12)7-9-3-5-13-6-4-9/h3-7H2,1-2H3

Upstream product

• 110-91-8 morpholine 
• 50-00-0 formaldehyd 
• 79-46-9 2-nitropropane 
• 76-39-1 2-nitro-2-methylpropanol 
• 5472-71-9 1-(4-morpholinomethyl)-1H-benzotriazole 
• 24163-39-1 sodium 2-nitropropane 

Downstream Products

• 6105-75-5 2-methyl-1-(morpholin-4-yl)propan-2-amine 

Relevant articles and documents

-

-

NOVEL BETULINIC SUBSTITUTED AMIDE DERIVATIVES AS HIV INHIBITORS

The present invention relates to novel betulinic substituted amide compounds of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, X, Y, Z1, Z2, Z3 and are Formula (II) as defined herein. The invention novel betulinic substituted amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

DIHYDROPTERIDINONES FOR THE TREATMENT OF CANCER DISEASES

The present invention relates to the use of a compound of general Formula (1), optionally in form of its tautomers, racemates, enantiomers, diastereomers and the mixtures thereof and optionally in form of the pharmacologically acceptable acid addition salts, solvates, hydrates, polymorphs, physiologically functional derivatives or prodrugs thereof, for the preparation of a pharmaceutical composition for the treatment of diseases characterized by abnormal cell proliferation in a human or non-human mammalian body by inhibition of polo like kinases as mitotic regulators.